• Protein A/G Magnetic Co-IP/IP Kit for AP2-M Studies

  2026-09-01

  Translate AP2-M transcriptional findings into practical protein-complex validation with magnetic immunoprecipitation. This workflow combines recombinant Protein A/G magnetic beads, controlled sample preparation, and orthogonal controls for Co-IP, SDS-PAGE, mass spectrometry, and antibody purification.

• Rapamycin (Sirolimus) mTOR Research Workflows

  2026-08-31

  Build more decisive mTOR experiments with Rapamycin (Sirolimus), from concentration-controlled neuronal assays to immunology, cancer, lens epithelial, and mitochondrial disease models. This guide connects pathway inhibition with practical controls, formulation advice, and troubleshooting strategies that help distinguish mechanism from assay artifact.

• GTP Solution (100 mM) for RNA Assays

  2026-08-31

  Learn how GTP Solution (100 mM), SKU K1044, can reduce upstream variability in in vitro transcription workflows that feed cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects defined nucleotide handling with p21 mRNA–LNP research while separating documented product specifications from laboratory recommendations.

• H 89 2HCl for Trigeminal Pain Studies

  2026-08-30

  Use H 89 2HCl to separate cAMP/PKA-dependent phosphorylation from the Ca2+-ERK1/2 and p38 signaling associated with trigeminal neuroinflammation. This workflow combines dose-controlled pharmacology, forskolin and ATP challenge assays, Piezo2-related readouts, and orthogonal validation to reduce misinterpretation from off-target kinase inhibition.

• Doxorubicin Hydrochloride: Assay Workflows

  2026-08-29

  Build more reproducible cytotoxicity, apoptosis, and cardiotoxicity experiments with Doxorubicin hydrochloride or Adriamycin HCl. This workflow-first guide connects concentration planning, fluorescence-aware readouts, and the latest oxidative-stress findings to practical cancer chemotherapy research.

• N4-Acetylcytidine Workflows for RNA Research

  2026-08-28

  N4-Acetylcytidine supports more than descriptive RNA modification studies: it can serve as a defined substrate, analytical reference, and mechanistic probe in nucleotide-processing workflows. This guide connects acetylated cytidine chemistry with enzyme assays, RNA structure-function analysis, and practical troubleshooting.

• Rotigotine Transdermal Delivery in PD and RLS

  2026-08-28

  The reference review explains how rotigotine’s lipid solubility and pharmacokinetic limitations of oral dosing led to development of a continuous transdermal system. Its synthesis of preclinical, pharmacokinetic, and randomized clinical evidence shows how stable dopaminergic stimulation can improve motor symptoms and off-time in Parkinson’s disease and symptoms of moderate-to-severe restless legs syndrome.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-27

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from iron-dependent lipid peroxidation and promotes tumor growth. By integrating m6A-RNA regulation, de-SUMOylation, iron chelation, organoid models, mouse genetics, and human samples, the study defines a potential route for sensitizing HCC to ferroptosis-based treatment.

• Minoxidil sulphate in vascular research workflows

  2026-08-27

  Build reproducible potassium-channel experiments with Minoxidil sulphate across perfused-kidney, vascular-cell, and hair-follicle models. This guide emphasizes assay design, vehicle control, mechanistic comparisons, and troubleshooting rather than treating a vasodilator as a standalone endpoint.

• O-propargyl-puromycin for Protein Synthesis Assays

  2026-08-26

  O-propargyl-puromycin (OPP) converts nascent translation into a measurable click-chemistry signal for cell biology, immunology, and proteomics workflows. This guide shows how to use OPP to connect global protein synthesis with mitochondrial fitness, B-cell function, stress responses, and assay troubleshooting.

• Cathepsin Proteases in Barley Leaf Senescence

  2026-08-26

  Schepetkin and Fischer combined substrate profiling, inhibitor analysis, activity-based labeling, and immunoblotting to characterize cathepsin B- and L-like protease activities during barley leaf senescence. Their results connect rising cysteine-protease activity with Rubisco degradation and nutrient-recycling biology while showing why inhibitor selectivity must be interpreted in the context of complex plant extracts.

• mTORC1–IRE1α in Palmitate Hepatocyte Lipotoxicity

  2026-08-25

  The reference study identifies an mTORC1–IRE1α signaling axis as a mechanistic link between palmitate metabolism, triglyceride overproduction, and hepatocyte death. Its inhibitor and metabolic-perturbation experiments suggest that saturated fatty acid processing, rather than fatty acid exposure alone, helps determine the lipotoxic response and provides a rationale for further pathway-focused investigation.

• RBMS1 Loss Enables PD-L1 Blockade in TNBC

  2026-08-25

  Zhang et al. identify the RNA-binding protein RBMS1 as a regulator of PD-L1 stability in immune-cold triple-negative breast cancer. Their data connect RBMS1-dependent B4GALT1 mRNA stability with PD-L1 glycosylation, tumor immune evasion, and improved responses to checkpoint-based or CAR-T treatment after RBMS1 depletion.

• Beyond Viability: Better Cancer Drug Response Metrics

  2026-08-24

  Hannah R. Schwartz’s dissertation shows why conventional viability readouts can obscure the distinction between proliferative arrest and actual cell killing. Its framework supports more informative cancer research workflows by pairing growth-inhibition measurements with time-resolved assessment of death and by interpreting each metric according to the biological process it captures.

• Methoxy-X04: Imaging Clearance in Alzheimer’s Models

  2026-08-24

  Exercise-induced skeletal muscle extracellular vesicles may improve cognition by reprogramming microglia and enhancing amyloid-beta plaque clearance. This thought-leadership guide examines how Methoxy-X04 can turn that mechanistic hypothesis into a measurable imaging workflow, while clarifying what plaque fluorescence can—and cannot—establish in translational Alzheimer’s disease research.

550 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page